Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Recent Updates in the Regulation of Nitrosamine Impurities

The regulation of nitrosamine impurities has been evolving rapidly due to concerns about their potential health risks, particularly their carcinogenicity. Regulatory authorities worldwide, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Therapeutic Goods
  • Nitrosamine
Pharmacy shopping and drug abuse

How to predict for the formation of NDSRIs ?

The detection of N-nitrosamine impurities in medicines and the increasing presence of nitrosamine drug substance-related impurities (NDSRIs) have presented significant challenges for both drug manufacturers and regulatory agencies.
  • Blog, Nitrosamine
Female pharmacist staring at packaged pharmaceutical drugs in her hands

What is the CPCA Category for Nitrosamine?

The CPCA for Nitrosamine simplifies the complex process of assessing nitrosamine impurities by categorizing them based on carcinogenic risk.
  • Nitrosamine
Multiethnic team of pharmaceutical researcher studying a new drug for diabetes

Part II : Nitrosamine Risk Assessment Questionnaire

Comprehensive information about the API’s chemical structure, properties, and synthesis process is crucial for identifying potential nitrosamine contamination sources.
  • Nitrosamine
Scientist man, woman and microscope with checklist in laboratory for research at pharma company. Sc

How to Calculate Acceptable Intake (AI) Limits for Nitrosamines?

Calculating acceptable intake (AI) limits for nitrosamines in pharmaceuticals is critical to ensuring patient safety. By accurately determining AI limits, we can minimize potential carcinogenic risks and maintain the highest standards of drug safety.
  • Nitrosamine
Researchers Evaluating Nitrosamine Presence to Calculate Acceptable Intake (AI) Limits for Enhanced Drug Safety.

Are Nitrosamines Hiding in Your Food? Tips to Avoid Them

Understanding the conditions that lead to nitrosamine formation is crucial for reducing their presence in our food. This article explores the science behind nitrosamine formation in cured meats and offers practical tips for minimizing their levels, ensuring a safer and
  • Nitrosamine

6 Steps to reduce nitrosamines impurities in Pharma industry

Implementing effective strategies involves six crucial steps: conducting thorough risk assessments, optimizing manufacturing processes, using high-purity raw materials, performing rigorous analytical testing, adhering to regulatory guidelines, and maintaining continuous monitoring and quality control. These measures collectively minimize nitrosamine risks in
  • Nitrosamine

The Role of Big Data in Nitrosamine Risk Assessment

In the pharmaceutical industry, nitrosamines pose significant health risks due to their carcinogenic potential. This blog explores how big data analytics revolutionizes nitrosamine risk assessment by enabling accurate monitoring and prediction. By leveraging vast datasets and predictive models, companies can
  • Nitrosamine

A Four-Step Guide to Nitrosamine Risk Assessment and Mitigation

Discover the crucial steps pharmaceutical manufacturers must take to assess and mitigate nitrosamine risks in drug products. Learn how meticulous risk assessment, rigorous testing, and proactive strategies ensure product safety and global compliance. Read on to protect your patients and
  • Nitrosamine
Quality depar